Afshine Emrani MD FACC

I’m a cardiologist. I prescribe cholesterol-lowering drugs every single day. They save lives. That science is settled and I will never tell you otherwise. But I’m going to say something that will make a lot of my colleagues uncomfortable — because someone needs to say it, and your doctor probably won’t.

Too many physicians make you feel crazy when you bring up statin side effects.
You walk into your appointment and say “my muscles ache constantly” — and you’re told it’s in your head. You say “I’m exhausted all the time” — and you’re told it’s your age. You say “my sex drive disappeared” — and you get an awkward silence followed by a subject change. You say “I don’t feel like myself anymore” — and you’re told the benefits outweigh the risks, take the pill, stop reading the internet.

I’ve watched it happen in my own field for twenty years. The conversation gets shut down. The patient gets dismissed. And then they do the one thing we should be most afraid of — they stop the medication entirely, without telling us, and lose the cardiovascular protection that’s keeping them alive.

That is the real cost of not being honest. Not the side effects themselves — the silence that drives patients away from treatment.

In my practice, I see statin-related complications in at least 25% of my patients. Muscle pain. Fatigue that doesn’t resolve with sleep. Reduced sexual drive. Brain fog. Cramping. Joint stiffness. Weakness that makes exercise — the very thing we tell them to do — feel impossible.

Some of these improve with CoQ10 supplementation and optimizing vitamin D. Many do not.

I wrote about the diabetes risk of statins in a New York Times op-ed in 2012. The backlash from the cardiology establishment was immediate. I was told I was undermining trust in a life-saving drug class. Fourteen years later, every major guideline acknowledges the risk I warned about. It’s in the prescribing information. The physicians who attacked me for saying it now teach it to their residents.

The truth doesn’t care about professional comfort. It never has.

Now a paper published this week in Science Advances has finally explained the mechanism behind statin myopathy — and the finding validates what millions of patients have been telling their doctors for years.

Researchers discovered that statins activate the NLRP3 inflammasome in muscle cells — triggering an inflammatory cascade that causes muscle cell death, activates atrophy pathways, and disrupts muscle metabolism. This is entirely independent of the drug’s cholesterol-lowering effect.

The muscle damage isn’t caused by lowering cholesterol. It’s caused by a completely separate pharmacological action through a different pathway.
The critical implication: the side effect can potentially be separated from the benefit.

Blocking NLRP3 or restoring isoprenoids prevented muscle cell death without interfering with cholesterol reduction. Future therapies could preserve the cardiovascular protection while eliminating the muscle toxicity.

Even more striking — the researchers found that background systemic inflammation significantly lowered the statin dose needed to trigger muscle damage. Patients with chronic inflammation, gut dysbiosis, or metabolic syndrome may be experiencing myopathy at doses their doctors consider “too low to cause problems.” They’re not imagining it. Their inflammatory state is priming the pathway.

The muscle pain was never in their heads. It was in their NLRP3 inflammasome. And we finally have the molecular proof.

Here’s what I actually do in my practice — because I refuse to choose between protecting the heart and respecting the patient.

Whenever possible, I avoid statins as my first-line approach for eligible patients by using alternatives that lower LDL through entirely different mechanisms with no muscle toxicity:

PCSK9 inhibitors — Repatha and Praluent. Injections every 2-4 weeks that dramatically lower LDL without touching muscle tissue. No myopathy. No fatigue. No brain fog. For patients who can access them, these are transformative.

Inclisiran — Leqvio. An siRNA injection I administer twice a year in my office. It silences the PCSK9 gene in the liver. Two shots a year. LDL drops roughly 50%. No muscle side effects. No daily pills. Now approved as first-line monotherapy. This is the future of lipid management and I use it aggressively.

When statins ARE clinically necessary — and sometimes they are, especially post-heart attack or in combination therapy — I choose hydrophilic statins like rosuvastatin or pravastatin. These do not easily cross the blood-brain barrier. The cognitive complaints — the fog, the memory issues, the feeling of “not being yourself” — are substantially less common with these formulations because the drug stays out of the central nervous system.

I never prescribe a statin without CoQ10. 100-300mg daily. Statins deplete the cellular energy molecule your muscles and heart depend on. Replenishing it reduces muscle symptoms in many patients. It should be standard practice. The fact that it isn’t is a failure of our field.

I check vitamin D and optimize it aggressively. Low vitamin D — which is epidemic — worsens muscle symptoms independently and compounds whatever the statin is doing. Target 50-80 ng/mL, not the bare minimum of 30.

Bempedoic acid — Nexletol — for patients who can’t tolerate any statin. Works upstream in the cholesterol pathway and is not active in muscle tissue. Specifically designed to avoid myopathy.

Ezetimibe added to a lower statin dose. Cut the statin intensity, add ezetimibe to maintain the LDL reduction, and halve the muscle exposure.

There is no excuse in 2026 for telling a patient “just deal with the muscle pain.” The toolbox is deep. The alternatives exist. The only barrier is a physician’s willingness to listen and adapt.

I want to speak directly to every patient who has been dismissed.

Your muscle pain is real. Your fatigue is real. Your cognitive changes are real. Your loss of drive — in every sense of the word — is real. A paper in Science Advances just proved the mechanism. You were never crazy. You were experiencing a documented inflammatory response in your muscle tissue that your doctor didn’t have the science to explain — until this week.

And I want to speak directly to my colleagues.

We have to be honest. Not just about the benefits — which are enormous and undeniable — but about the side effects, the mechanism, and the alternatives. Patients who feel heard stay on treatment. Patients who feel dismissed stop their medications in silence — and die from the heart attacks we could have prevented if we’d simply been willing to have an honest conversation and switch the approach.

The cardiologist who tells you statins are flawless is not protecting you. The wellness influencer who tells you statins are poison is not protecting you either. The truth lives in the middle — where it always has.

Statins save lives. The side effects are real. The mechanism is now proven. The alternatives exist. And you deserve a doctor who holds all four of those truths at the same time.

Both things can be true. They always could.
Now we have the science to prove it.